ALP Antibody (Rabbit mAb) [B19A18]

CatNo: F5591

    Application: Reactivity:

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:500-1:1000
    1:1000
    Application
    WB, IHC
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    39 kDa 43 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。

    Datasheet & SDS

    生物学的記述

    Specificity
    ALP Antibody (Rabbit mAb) [B19A18] detects endogenous levels of total ALP protein.
    Clone
    B19A18
    Synonym(s)
    ALP, PDLIM3, PDZ and LIM domain protein 3, Actinin-associated LIM protein, Alpha-actinin-2-associated LIM protein
    Background
    ALP belongs to the PDZ-LIM family of actin-associated scaffold proteins, structurally defined by an N-terminal PDZ domain and a C-terminal LIM domain that together mediate direct binding to α-actinin. ALP colocalizes with α-actinin at the Z-discs of striated muscle, where the PDZ-LIM architecture links the protein to the actin-binding surface of the α-actinin spectrin-repeat region, positioning ALP as a structural scaffold rather than an enzymatic regulator. ALP expression rises sharply during myogenic differentiation, and disruption of ALP expression reduces transcript levels of the muscle regulatory factors myogenin and MyoD, placing ALP function upstream of the core myogenic transcriptional program. Loss of ALP causes a marked reduction in organized actin filament bundles within differentiating muscle cells, and this cytoskeletal disruption directly suppresses the activity of serum response factor, a transcription factor whose activation depends on actin polymerization state and the nuclear availability of its coactivator MAL. Restoring MyoD expression in ALP-depleted cells is sufficient to rescue myogenic differentiation despite persistent actin bundle loss, indicating that ALP acts through the actin-SRF-MyoD axis to control entry into the differentiation program rather than through a parallel independent pathway. Treatment with an actin-stabilizing compound restores SRF activity and differentiation capacity in ALP-depleted cells, reinforcing that ALP's contribution to myogenesis operates through maintenance of filamentous actin architecture. PDZ-LIM family members, including ALP, interact with the CH and spectrin-repeat domains of α-actinin isoforms across muscle and non-muscle contexts, supporting roles in both Z-disc stability and, in emerging evidence, actin-dependent membrane trafficking. Z-disc scaffold proteins of this family, including ALP, are implicated in the structural integrity of cardiac and skeletal sarcomeres, with disruption linked to cardiomyopathy susceptibility in genetic association studies.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください